California

California Biopharmaceuticals is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of cancer and other serious diseases. The company leverages its expertise in molecular biology and drug discovery to develop a pipeline of targeted therapies, including monoclonal antibodies and small molecules. Their primary research efforts are directed toward inhibiting key pathways involved in tumor growth and angiogenesis, such as the VEGF and EGFR pathways. California Biopharmaceuticals aims to address significant unmet medical needs by providing more effective and safer treatment options for patients with various solid tumors.